Cognitively Unimpaired

3

Review clinical trials related to Cognitively Unimpaired. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression

The goal of this observational study is to improve the detection of dementia with Lewy bodies (DLB) and its prodromal phases, as well as advancing our current understanding of biological mechanisms and therapeutic options. The data is acquired at cognitive clinics in Stockholm (Sweden) and combined with national and international data to increase statistical power, representativeness and replication of results. Participants undergo collection of clinical assessments, neuroimaging and fluid biomarkers.

Participants needed: 600
Trial details
Biological sex: AllType: ObservationalSponsor: Karolinska InstitutetUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

At least one core clinical feature of dementia with Lewy bodies such as visual h...

Causes of cognitive impairment other than those related to dementia or MCI. Curr...

Status: Not yet recruiting

Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI

The goal of this clinical trial is to determine whether acoustic stimulation during sleep can enhance slow-wave sleep (SWS), improve cognitive function, and reduce AD-related pathology in individuals with mild cognitive impairment (MCI), compared with cognitively healthy participants. The main questions it aims to answer are: 1. Does acoustic stimulation increase SWS (e.g., slow oscillation and sleep spindle activity) in individuals with MCI? 2. Does enhancing SWS lead to improvements in memory and cognitive performance? 3. Does acoustic stimulation influence plasma p-tau217 levels as a marker of underlying Alzheimer's disease pathology? Researchers will compare participants receiving acoustic stimulation during sleep with those not receiving stimulation to evaluate its effects on sleep architecture, cognition, and plasma biomarkers. Participants will: * Undergo sleep recordings to assess sleep architecture, including SWS, slow oscillations, and sleep spindles * Receive acoustic stimulation during sleep across multiple nights * Complete cognitive assessments, particularly memory-related tasks * Provide blood samples to measure plasma p-tau217 levels * Provide clinical and demographic information for analysis

Participants needed: 114
Trial details
Age: 60+Biological sex: AllType: InterventionalSponsor: Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida)Updated: Apr 14, 2026Locations: 1
Eligibility criteria

Diagnosis of aMCI according to the NIA-AA criteria (Albert et al., 2011) and pos... [+2]

Diagnosis of dementia due to AD or any other type of dementia. [+9]

Status: Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

This is a longitudinal observational study recruiting individuals between the ages of 50 and 90 with different types of dementia as well as a comparison group without cognitive deficits. Participants are/will be recruited at sites across Canada and will undergo assessments, neuroimaging, and biological sample collection.

Participants needed: 1,573
Trial details
Age: 50-90Biological sex: AllType: ObservationalSponsor: McGill UniversityUpdated: Jan 20, 2026Locations: 19
Eligibility criteria

Has subjective or objective cognitive impairment [+6]

The presence of other significant known chronic brain disease such as: moderate... [+3]